fingolimod hydrochloride has been researched along with masoprocol in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (masoprocol) | Trials (masoprocol) | Recent Studies (post-2010) (masoprocol) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 1,527 | 8 | 163 |
| Protein | Taxonomy | fingolimod hydrochloride (IC50) | masoprocol (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 3.5 | |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | 3.5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alatrag, F; Amoni, M; Gwanyanya, A; Kelly-Laubscher, R | 1 |
1 other study(ies) available for fingolimod hydrochloride and masoprocol
| Article | Year |
|---|---|
Cardioprotective effect of fingolimod against calcium paradox-induced myocardial injury in the isolated rat heart.
Topics: Animals; Calcium; Cardiotonic Agents; Fingolimod Hydrochloride; In Vitro Techniques; Magnesium; Male; Masoprocol; Myocardial Infarction; Rats, Wistar; TRPM Cation Channels | 2022 |